People in conference room, seen through semi-opaque glass wall
·
4 Min Read

How the 10 largest PBMs hold huge sway in health care marketplace

First-of-its-kind data on pharmacy benefit managers (PBMs) analyzed in AMA report shows widespread, high market concentration.

Access to Care
UPDATED
·
2 Min Read

Prescription drugs: CSAPH reports

Download PDFs of reports on this topic for the Council on Science and Public Health (CSAPH) presented during the AMA Interim and Annual Meetings.

Science & Public Health
·
4 Min Read

AMA examines PBM market competition and integration with insurers

First-of-its-kind data assess national and local markets for commercial PBM services.

Press Releases
Two masked people working in front of a laptop
·
3 Min Read

Michigan State training helps overcome addiction’s stigma

Medical students, physicians are eager to learn how to better care for patients living with substance-use disorders. Learn more with the AMA.

ChangeMedEd Initiative
·
1 Min Read

New guidance on naloxone to strengthen work of harm reduction groups

The guidance announced today offers regulatory clarity for harm reduction organizations to purchase naloxone so more will be distributed in communities.

Press Releases
·
2 Min Read

Sept. 16, 2022: Advocacy Update spotlight on 2022 Overdose report

AMA 2022 Overdose Report shows worsening epidemic, need for all-hands approach and more in the latest Advocacy Update spotlight.

Advocacy Update
Two hands reaching out
·
4 Min Read

Barriers to care cause drug overdose and death epidemic to deepen

Illicit drugs are fueling the overdose epidemic. A new AMA report makes clear how physicians, payers, policymakers and others can help save lives.

Behavioral Health
·
3 Min Read

Trends on overdose deaths require specific actions, all-hands approach

With a report issued today detailing the horrific toll of the nation’s overdose and death epidemic, the AMA calls for an all-hands approach to help save lives.

Press Releases
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Aug. 29, 2022

In the news: Bivalent COVID boosters gets FDA approval, new fentanyl pills target youth, decline in new monkeypox cases and more.

Publications & Newsletters